Skip to main content
SpringerLink
Log in

Therapeutic Uses of Beta-Blockers in Psychosomatics

  • Chapter
Psychosomatic Medicine

  • 141 Accesses

Abstract

The present status and future prospect of beta-blockers in clinical psychiatry remain provocatingly controversial but stimulating enough to warrant the review of the available literature for ever expanding therapeutic applications. Psychiatrists in recent years have been exploring the therapeutic uses of beta-blockers in the management of (1) Anxiety Neurosis, (2) temporary life stress situation, (3) Lithium induced tremor, (4) alcoholic withdrawal syndrome, (5) opiate withdrawal, (6) for control of aggression and rage, and (7) schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenblatt, D., Shaker, R. On the psychopharmacology of beta-blockade. Curr. Ther. Res. 14: 615–625, 1972.

    PubMed  CAS  Google Scholar 

  2. Granville-Grossman, K.L., Turner, P. The effect of propranolol on anxiety. Lancet 1: 788–790, 1966.

    Article  PubMed  CAS  Google Scholar 

  3. Kellner, R., Collins, A.C., Shulman, R.S. The short-term anti-anxiety effects of propranolol Hcl. J. Clin. Pharmacol. 14: 301–304, 1974.

    PubMed  CAS  Google Scholar 

  4. Tanna, V., Penningroth, R., Wollson, R. Propranolol in the treatment of anxiety neurosis. Comp. Psychiat. 18: 319–326, 1977.

    Article  CAS  Google Scholar 

  5. Bonn, J.A., Turner, P. D-propranolol and anxiety. Lancet 1: 1355–1356, 1971.

    Article  PubMed  CAS  Google Scholar 

  6. Burrows, G., Davies, B., Fail, L. A placebo controlled trial of diazepam and oxprenolol for anxiety. Psychopharmacology 50: 177–179, 1976.

    Article  PubMed  CAS  Google Scholar 

  7. Johnson, G., Singh, B., Leeman, M. Controlled evaluation of the beta adrenorecptor blocking drug oxprenolol in anxiety. Med. J. Australia 1: 909–912, 1976.

    CAS  Google Scholar 

  8. Suzman, M.M. The use of beta-adrenergic blockage with propranolol in anxiety states. Postgrad. Med. J. 47: 104–108, 1971.

    Google Scholar 

  9. Becker, A.L. Oxprenolol and propranolol in anxiety states: a double-blind comparative study. So. African Med. J. 50: 627629, 1976.

    Google Scholar 

  10. Suzman, M.M. Propranolol in the treatment of anxiety. Postgrad. Med. J. 52 (Suppl. 4): 168–174, 1976.

    Google Scholar 

  11. Tyrer, P.J., Lader, M.H. Effects of beta adrenergic blockade with sotalol in chronic anxiety. Clin. Pharmacol. Ther. 14: 418–426, 1973.

    PubMed  CAS  Google Scholar 

  12. Easton, J.D., Sherman, D. Somatic anxiety attacks and propranolol. Arch. Neurol. 33: 689–691, 1976.

    CAS  Google Scholar 

  13. Bonn, J.A., Turner, P., Hicks, D.C. Beta-adrenergic receptor blockade with practolol in treatment of anxiety. Lancet 1: 814–815, 1972.

    Article  PubMed  CAS  Google Scholar 

  14. Tyrer, P.J., Lader, M.H. Response to propranolol and diazepam in somatic and psychic anxiety. Br. Med. J. 2: 14–16, 1974.

    Article  PubMed  CAS  Google Scholar 

  15. Singh, A.M. Clinical experiences with beta-blockers in psychiatry. Symp. of Beta-blockers in cardiology and psychiatry. O.M.A. Annual Mtg., 1980 (in press).

    Google Scholar 

  16. Hawkings, J. Clinical experience with beta-blockers in consultant psychiatric practice. Scottish Med. J. 20: 294–298, 1975.

    CAS  Google Scholar 

  17. Brewer, C. Beneficial effect of beta-adrenergic blockade on “exam nerves.” Lancet 2: 435, 1972.

    Article  PubMed  CAS  Google Scholar 

  18. Krishnan, G. Oxprenolol in the treatment of examination nerves. Scottish Med. J. 20: 288–289, 1975.

    CAS  Google Scholar 

  19. James, I., Pearson, R., Griffith, D. Effect of oxprenolol on stage-fright in musicians. Lancet 2: 952–954, 1977.

    Article  PubMed  CAS  Google Scholar 

  20. Kirk, L. Baastrup, P.C., Schou, M. Propranolol and lithium-induced tremor. Lancet 1972/I,839; corresp.

    Google Scholar 

  21. Floru, L. Klinische Behandlungsversuche des lithiumbedingten Tremors durch einen B-Rezeptorenantagonisten (Propranolol). Int. Pharmacopsychiat. 6, 197 (1971).

    CAS  Google Scholar 

  22. Kirk, L.,Baastrup, P.C., Schou, M. Propranolol treatment of lithium-induced tremor. Lancet 1973 (II, 1086: corresp.)

    Google Scholar 

  23. Kirk, L., Baastrup, P.C., Schou, M. Propranololbehandlung bei Lithium tremor. Nervenarzt 44, 657, 1973.

    PubMed  CAS  Google Scholar 

  24. Rafaelson, O. Discussion. In Kielholz, P. (Ed): Beta-blockers and the Central Nervous System. Baltimore, Univ. Park Press, 1976, pp. 231–234.

    Google Scholar 

  25. Freedman, A. Beta-blockers in the treatment of alcoholism and opiate addiction. In Kielholz, P. (Ed): Beta-blockers and the Central Nervous System, Baltimore, Univ. Park Press, 1976, pp. 141–148.

    Google Scholar 

  26. Carlsson, C. Haemodynamic effects of adrenergic beta-receptor blockade in the withdrawal phase of alcoholism. Internat. J. Clin. Pharmacol. 3: 61–63, 1969.

    Google Scholar 

  27. Carlsson, C., Johansson, T. The psychological effects of propranolol in the abstinence phase of chronic alcoholics. Br. J. Psychiat. 119: 605–606, 1971.

    Article  CAS  Google Scholar 

  28. Sellers, E., Zilm D., Degani, N. Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J. Studies Alcohol 38: 2096–2108, 1977.

    CAS  Google Scholar 

  29. Gunne, L.M. Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal. Acta physiol. scand. 58, Suppl. 204, 1963.

    Google Scholar 

  30. Grosz, H.J. Effect of propranolol on active users of heroin. Lancet 1973/II,612.

    Google Scholar 

  31. Hollister, L.E., Prusmack, J.J. Propranolol in withdrawal from opiates. Arch. gen. Psychiat. 31, 695, 1974.

    Article  PubMed  CAS  Google Scholar 

  32. Ressnick, R.B., Kestenbaum, R.S., Schwartz, L.K., Smith, A. Evaluation of propranolol in opiate dependence. Arch. gen. Psychiat. 33, 993, 1976.

    Article  Google Scholar 

  33. Elliott, F.A. Ann Neurol 1: 489–491, 1977.

    Article  PubMed  CAS  Google Scholar 

  34. Yudofsky, S. Am. J. Psychiatry 108, 218–220, 1981.

    Google Scholar 

  35. Petrie, M.M., Ban, T.A. Lancet 1: 325, 1981.

    Google Scholar 

  36. Manshein, P. J. Clin. Psychiatry 42: 132, 1981.

    Google Scholar 

  37. Shevitz. J. Nerv. Ment. Dis. 168: 246–48, 1980.

    Article  CAS  Google Scholar 

  38. Schreier, H.A. Am. J. Psychiatry 136: 840–41.

    Google Scholar 

  39. Yorkston, N., Zaki, S., Havard, C. Some practical espects of using propranolol in the treatment of schizophrenia. In Robert E. Amacher, P. (Eds): Propranolol and Schizophrenia, New York, Liss, 1978, pp. 83–97.

    Google Scholar 

  40. Atsom, A., Blum, I., Wijsenbeek, H. The short-term effects of adrenergic-blocking agents in a small group of psychotic patients. Psychiat. Neurol. Neurochir. 74: 251–258, 1971.

    Google Scholar 

  41. Atsmon, A., Blum, I. The discovery. In Roberts, E., Amacher, P. (Eds): Propranolol and Schizophrenia, New York, Liss, 1978, pp. 5–38.

    Google Scholar 

  42. Yorkston, N., Zaki, S., Malik, M. Propranolol in the control of schizophrenic symptoms. Br. Med. J. 4: 633–635, 1974.

    Article  PubMed  CAS  Google Scholar 

  43. Yorkston, N., Zaki, S., Havard, C. Propranolol in the treatment of schizophrenia; an uncontrolled study with 55 adults. In Roberts, E., Amacher, P. (Eds): Propranolol and Schizophrenia, New York, Liss, 1978, pp. 39–67.

    Google Scholar 

  44. Yorkston, N., Zaki, S., Themen, J. Safeguards in the treatment of schizophrenia with propranolol. Postgrad. Med. J. 52 (Suppl. 4): 175–180, 1976.

    PubMed  Google Scholar 

  45. Yorkston, N., Gruzelier, J., Zaki, S. Propranolol as an adjunct to the treatment of schizophrenia. In Roberts, E., Amacher, P. (Eds): Propranolol and Schizophrenia. New York, Liss, 1978, pp. 69–82.

    Google Scholar 

  46. Volk, W., Bier, W., Braun, J. Treatment of excited psychosis with a beta-blocker receptor (oxprenolol) in high dosages. Nervenartzt 43: 491–492, 1972.

    CAS  Google Scholar 

  47. Hanssen, T., Heyden, T., Sundberg, I. Propranolol in Schizophrenia. Arch. Gen. Psychiatry, 1980, 37: 685–90.

    Article  PubMed  CAS  Google Scholar 

  48. Lindstorm, I.H., Persson, E. Propranolol in chronic Schizophrenia; a controlled study in neuroleptic treated patients. Br. J. Psychiat., 1980, 137: 126–30.

    Article  Google Scholar 

  49. Gardos, G., Cole, J., Volicer, L. A dose-response study of propranolol in schizophrenics. Curr. Ther. Res. 15: 314–323, 1973.

    PubMed  CAS  Google Scholar 

  50. Rackensperger, W., Gauppe, R., Mattke, D. Treatment of acute Schizophrenic psychoses with beta-receptor blockers. Arch. Psychiat. Nervenkrank 219: 29–36, 1974.

    Article  CAS  Google Scholar 

  51. Gruzelier, J., Thronton, S., Stanforth, S. Active and passive avoidence barring on racemic propranolol and neuroleptics. Br. J. Psychiat., 1980, 137: 131–37.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hamilton Psychiatric Hospital, Hamilton, Ontario, Canada, L8N 3K7

    A. N. Singh

Authors
  1. A. N. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychosomatic Service and Research, Champlain Valley Physicians, Hospital Medical Center, 12901, Plattsburgh, New York, USA

    Adam J. Krakowski M.D. (Chief) (Chief)

  2. Department of Psychiatry, Pritzker School of Medicine, The University of Chicago, 950 East 59th Street, Chicago, Illinois, USA

    Chase Patterson Kimball M.D. (Professor of Psychiatry and Medicine) (Professor of Psychiatry and Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Plenum Press, New York

About this chapter

Cite this chapter

Singh, A.N. (1983). Therapeutic Uses of Beta-Blockers in Psychosomatics. In: Krakowski, A.J., Kimball, C.P. (eds) Psychosomatic Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4496-4_89

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4496-4_89

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4498-8

  • Online ISBN: 978-1-4684-4496-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation